UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
AN-CON GENETICS, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
032347205
(CUSIP Number)
Mr. Gregory Konesky Irwin A. Kishner, Esq.
3 Rolling Hill Road Herrick, Feinstein LLP
Hampton Bays, New York 11946 2 Park Avenue
Tel.: (516) 728-4164 New York, New York 10016
(212) 592-1400
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
February 9, 1998
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4),
check the following box .
Check the following box if a fee is being paid with the statement.
(A fee is not required only if the reporting person: (1) has a
previous statement on file reporting beneficial ownership of more
than five percent of the class of securities described in Item 1;
and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See
Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should
be filed with the Commission. See Rule 13d-1(a) for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filed out for a reporting
person's initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover
page.
The information required on the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
(Continued on following page(s))
Page 1 of 5 Pages
<PAGE>
CUSIP NO. 032347205 13D Page 2 of 5 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
GREGORY KONESKY
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
(b)
3 SEC USE ONLY
4 SOURCE OF FUNDS*
OO
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7 SOLE VOTING POWER
750,000 shares of Common Stock
8 SHARED VOTING POWER
None
9 SOLE DISPOSITIVE POWER
750,000 shares of Common Stock
10 SHARED DISPOSITIVE POWER
None
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
750,000 shares of Common Stock
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.6%
14 TYPE OF REPORTING PERSON*
IN
* SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION
Page 2 of 5 Pages<PAGE>
PART II TO SCHEDULE 13D
Item
1. Security and Issuer
Shares of Common Stock
An-Con Genetics, Inc.
One Huntington Quadrangle
Suite 1N11
Melville, New York 11747
(hereinafter, the "Issuer")
Item 2. Identity and Background
(1) (a) Name: Gregory Konesky
(b) 3 Rolling Hill Road
Hampton Bays, New York 11946
(c) Sole practitioner as a technology consultant, 3
Rolling Hill Road, Hampton Bays, New York 11946
(d) Information required by Item 2(d): None.
(e) Information required by Item 2(e): None.
(f) United States of America.
Item 3. Source and Amount of Funds or Other Consideration
Mr. Konesky acquired the securities in accordance
with the terms and provisions of the Securities Exchange Agreement
described in Item 5(a). The securities were exchanged for a
$750,000 aggregate principal amount convertible debenture issued
by BSD Development Beta Corporation ("BSD") which was convertible
into 75 shares of the common stock of BSD subject to the terms and
conditions thereof.
Item 4. Purpose of Transaction
(a) The shares of common stock of the Issuer ("Common
Stock") were acquired with a view to the short-
term resale of such shares of Common Stock.
Immediately following the consummation of the
securities exchange described in Item 5 (a), BSD
became a wholly owned subsidiary of the Issuer. At such time
the assets of BSD included certain
equipment, licensing arrangements and other intangible
rights, cash in the amount of $250,000, and
a $750,000 aggregate principal amount promissory
note due May 10, 1998.
(b)-(j) The undersigned has no plans or proposals
which would result in any of the actions enumerated in
Item 4(b) through (j) of Schedule 13D.
Page 3 of 5 Pages<PAGE>
Item 5. Interest in Securities of the Issuer
(a) Gregory Konesky ("Konesky") on February 9, 1998
acquired 750,000 shares of Common Stock of the
Issuer, representing approximately 5.6% of such
class of securities of the Issuer. The
acquisition of such Common Stock by Konesky was
pursuant to the terms and conditions of the
Securities Exchange Agreement, executed and
delivered on February 9, 1998 among the Issuer
and Konesky and other security holders of BSD.
Konesky acquired the common stock of the Issuer
by exchanging a $750,000 aggregate principal
amount convertible debenture which was
convertible into 75 shares of the common stock of
BSD subject to the terms and conditions thereof.
The exchange was consummated in New York, New
York.
(b) Konesky has the sole power to vote or to direct
the vote and the sole power to dispose or to
direct the disposition of the shares of Common
Stock.
(c) None.
(d) None.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer
The shares of Common Stock of the Issuer are subject to
a Registration Rights Agreement dated February 9, 1998 among the
Issuer, Konesky and other stockholders of the Issuer.
Konesky has agreed that until February 8, 1999 he will
vote all shares of the common stock of the Issuer which are
registered in his name in accordance with the written instructions
of a majority of the Board of Directors of the Issuer or pursuant to
its order.
The shares of common stock of the Issuer are not
registered under the Securities Act of 1933, as amended, and are
subject to certain transfer restrictions by the Issuer and
applicable law.
Item 7. Materials to be Filed as Exhibits
None.
Page 4 of 5 Pages<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.
February 19, 1998 /s/ Gregory Konesky
Date Signature
Gregory Konesky
Page 5 of 5 Pages
